Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours "REVASCAT"

Terminated

Phase 3 Results N/A

Summary of Purpose

To evaluate the hypothesis that mechanical embolectomy with the Solitaire FR device is superior to medical management alone in achieving favorable outcome in the distribution of the modified Rankin Scale scores at 90 days in subjects presenting with acute large vessel ischemic stroke < 8 hours from symptom onset. Trial Stopped: Following DSMB advice after first interim analysis (n=174)

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 February 2016.

1 Nov 2012 20 Sep 2012 1 Mar 2015 1 Dec 2015 1 Feb 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Antoni Dávalos, MD

  • Tudor Jovin, MD